Scott Lain
Healthcare Consultant
Indianapolis, IN, US
Scott Lain is a healthcare consultant in the Health Practice in Milliman's Indianapolis office. He joined the firm in 2017.
Experience
Scott supports consulting engagements with pharmaceutical manufacturers and health plans on topics such as market access, policy evaluation, and financial forecasting. Scott values an analytical approach to strategy and decision-making, specializing in the development of dynamic models and interactive tools.
Scott has led or supported a variety of projects on topics, including:
- Developing Medicare Part D strategy and tactics, including Inflation Reduction Act impact and strategic response
- Projecting cell and gene therapy utilization though clinical research and claims data analysis
- Consolidating data assets into dashboards and reporting tools to identify business risks and opportunities
- Assessing policy through qualitative and quantitative efforts to capture potential risks and impacts
- Developing and supporting multi-functional contracting models
- Supporting product launches through pricing, customer targeting, implementation, and pull-through activities
- Creating and facilitating training materials on topics such as Medicare, the Inflation Reduction Act, the product launch process, and others
- Developing infographics and whitepapers for use by advocacy and policy groups
Publications and Presentations
- Alzheimer's disease: An analysis of the diagnosed population and out-of-pocket cost exposure (https://us.milliman.com/en/insight/alzheimers-disease-diagnosed-population-out-of-pocket-cost)
- Mitigating out-of-pocket costs for insulin users (https://www.milliman.com/en/insight/mitigating-out-of-pocket-costs-for-insulin-users)
- Diabetes burden on population groups: Research summary (https://www.milliman.com/en/insight/diabetes-burden-on-population-groups-research-summary)
Education
- BS with high distinction, Business Analytics, Indiana University
- BS with high distinction, Supply Chain Management, Indiana University
Publications
Read their latest work
Article
Alzheimer's disease: An analysis of the diagnosed population and out-of-pocket cost exposure
28 February 2024 - by Jessica Naber, Scott Lain
More than 98% of Medicare beneficiaries who may be considered for amyloid-targeting therapy have coverage that limits or caps out-of-pocket exposure.
Article
Diabetes burden on population groups: Research summary
22 July 2019 - by Matt Berman, Scott Lain
This report provides data on the burden of diabetes on various subsets of the U.S. population.
Article
Mitigating out-of-pocket costs for insulin users
30 May 2019 - by Matt Berman, Scott Lain, Luke Metz
This report identifies potential approaches that plan administrators could take in an effort to reduce out-of-pocket costs for insulin-taking members.